Anti-PSCA monoclonal antibody - Astellas Pharma
Alternative Names: AGS-1C4D4; AGS-PSCA; MK-4721Latest Information Update: 05 Nov 2023
Price :
$50 *
At a glance
- Originator Agensys
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pancreatic cancer; Prostate cancer
Most Recent Events
- 02 Nov 2012 Discontinued - Phase-I for Prostate cancer in USA (IV)
- 02 Nov 2012 Discontinued - Phase-II for Pancreatic cancer in Canada (IV)
- 02 Nov 2012 Discontinued - Phase-II for Pancreatic cancer in France (IV)